Number of shares outstanding for Ligand Pharmaceuticals (LGND)

Number of shares outstanding as of October 2026 : 20,063,000

According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 20,063,000. At the end of 2026 the company had 20,063,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Ligand Pharmaceuticals from 2022 to 2026

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2026	20.06 M	1.71%
2025	19.72 M	3.96%
2024	18.97 M	8.63%
2023	17.46 M	3.41%
2022	16.89 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Johnson & Johnson JNJ	2,408,228,000	11,903.33%	🇺🇸 USA
Pfizer PFE	5,699,000,000	28,305.52%	🇺🇸 USA
Eli Lilly LLY	891,500,000	4,343.50%	🇺🇸 USA
Amgen AMGN	540,000,000	2,591.52%	🇺🇸 USA
Baxter BAX	517,000,000	2,476.88%	🇺🇸 USA
Merck MRK	2,468,643,335	12,204.46%	🇺🇸 USA
Bristol-Myers Squibb BMY	2,042,000,000	10,077.94%	🇺🇸 USA
GSK plc GSK	2,007,000,000	9,903.49%	🇬🇧 UK
Spectrum Pharmaceuticals SPPI	201,918,066	906.42%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions